Episode
Trump’s Psychedelic Order: Breakthrough...or Bad Trip?
- Podcast
- CNN One Thing
- Published
- Apr 22, 2026
- Duration seconds
- 1330
- Processing state
not_requested
Actions
POST https://stenobird.com/v1/public/podcasts/cnn-one-thing-5645403/episodes/trump-s-psychedelic-order-breakthrough-or-bad-trip/transcription-requests
Idempotently request low-priority transcript generation for this episode.GET https://stenobird.com/podcast/cnn-one-thing-5645403/trump-s-psychedelic-order-breakthrough-or-bad-trip.md
Read the agent-friendly Markdown representation of this episode resource.
Summary
President Donald Trump signed an executive order on Saturday aimed at beefing up research of psychedelic drugs like ibogaine that could be used in mental health treatments. Some veterans and people who have struggled with addiction who have used ibogaine say this could be a breakthrough that could lead to wider access, but some medical experts are warning approvals shouldn’t be rushed. We hear why a leading advocate group says while it’s a good start – much more has to be done. For more: Trump accelerates research on psychedelic treatments and asks, ‘Can I have some?’ --- Guests: Samantha Juan & Melissa Lavasani, Psychedelic Medicine Coalition Founder/CEO Host: David Rind Producer: Paola Ortiz Showrunner: Felicia Patinkin Editorial Support: Katherine Dillinger Photo: Jim Watson/AFP/Getty Images Learn more about your ad choices. Visit podcastchoices.com/adchoices